Although the underlying mechanisms of action of CF on airway inflammation and anti-asthmatic activity are not clear at present, from the aforementioned reports, it is likely that CF regulates the MAPK cascade via the EGF receptor and/or possible regulators of the NF-κB signalling pathway. This evidence concerns the gene NFKB1 and cystic fibrosis.